Olympus extends into stents acquiring Taewoong Medical for $370M

Tokyo, Japan & Seoul, South Korea, February 24, 2023 (Olympus) -- Olympus Corporation (Olympus), a global medtech company committed to making people’s lives healthier, safer and more fulfilling, has agreed to acquire Taewoong Medical Co., Ltd, (Taewoong Medical), a Korea-based manufacturer of medical devices such as gastrointestinal (GI) metallic stents1 to strengthen its GI EndoTherapy product portfolio capabilities, and in turn, contributing to improving patient outcome through comprehensive solutions.

Read full article here.